References for Post-Transplant Complications for Clinicians

1. Bharadwaj S, Tandon P, Gohel TD, et al. Current status of intestinal and      multivisceral transplantation. Gastroenterology Report. 2017;5(1):20-28. doi:10.1093/gastro/gow045.

2. Wu T, Abu-Elmagd K, Bond G, Nalesnik MA, Randhawa P, Demetris AJ. A schema for histologic grading of small intestine allograft acute rejection. Transplantation. 2003;75(8):1241-1248. doi:10.1097/01.TP.0000062840.49159.2F

3. Mazariegos, G.V., Abu‐Elmagd, K., Jaffe, R., Bond, G., Sindhi, R., Martin, L., Macedo, C., Peters, J., Girnita, A. and Reyes, J. (2004), Graft Versus Host Disease in Intestinal Transplantation. American Journal of      Transplantation, 4: 1459-1465. doi:10.1111/j.1600-6143.2004.00524.x

4. Florescu DF, Langnas AN, Sandkovsky U. Opportunistic viral infections in intestinal transplantation. Expert Rev Anti Infect Ther. 2013;11(4):367-381. doi:10.1586/eri.13.25

5. Abu-Elmagd KM, Kosmach-Park B, Costa G, et al. Long-term survival, nutritional autonomy, and quality of life after intestinal and multivisceral transplantation. Ann Surg. 2012;256(3):494-508. doi:10.1097/SLA.0b013e318265f310

6. Valenzuela NM, Reed EF. Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies. J Clin Invest. 2017;127(7):2492-2504. doi:10.1172/JCI90597

7. Abu-Elmagd KM. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines. Gastroenterology. 2006;130(2 Suppl 1):S132-S137. doi:10.1053/j.gastro.2005.09.069

8. Kitamura K, Buchholz BM, Abu-Elmagd K, Kalff JC, Schäfer N, von Websky MW. Chronic rejection after intestinal transplantation: A systematic review of experimental models. Transplant Rev (Orlando). 2019;33(3):173-181. doi:10.1016/j.trre.2019.04.001

9. Cimino FM, Snyder KA. Primary Care of the Solid Organ Transplant Recipient. Am Fam Physician. 2016;93(3):203-210.

10. Abu-Elmagd KM, Zak M, Stamos JM, et al. De novo malignancies after intestinal and multivisceral transplantation. Transplantation. 2004;77(11):1719-1725. doi:10.1097/01.tp.0000131164.43015.4b

11. Doshi, M. D. (2016). Cancer in Solid Organ Transplantation. In Onco-Nephrology Curriculum. Detroit, MI: American Society of Nephrology.

12. Abu-Elmagd KM, Mazariegos G, Costa G, et al. Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks. Transplantation. 2009;88(7):926-934. doi:10.1097/TP.0b013e3181b7509c

13. Gross, T. (2008). Management of Posttransplant Lymphoproliferative Disease. In A. Langnas, O. Goulet, E. Quigley, & K. Tappenden (Eds.), Intestinal Failure: Diagnosis, Management, and Transplantation (pp. 342-347). Blackwell Publishing.

14. Florescu DF, Abu-Elmagd K, Mercer DF, Qiu F, Kalil AC. An international survey of cytomegalovirus prevention and treatment practices in intestinal transplantation. Transplantation. 2014;97(1):78-82. doi:10.1097/TP.0b013e3182a6baa2